MPG.eBooks - Search Results - "

Cover Image

141

Dental scaling and root planing for periodontal health : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

142

Dental space maintainers for the management of premature loss of deciduous molars : a review of the clinical effectiveness, cost-effectiveness and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

143

Timely access to primary care for patients with chronic diseases : a review of clinical benefit, cost-effectiveness, and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

144

Vein illumination devices for vascular access : a review of clinical effectiveness

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

145

Aripiprazole (Abilify) : depression, major depressive disorder (MDD)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

146

Fluticasone furoate/Vilanterol (Breo ellipta)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

147

Galsulfase (Naglazyme)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

148

Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/COBI/FTC/TAF) (Genvoya) fixed-dose combination, oral tablet

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

149

Mepolizumab (Nucala)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

150

Canakinumab (Ilaris)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

151

PRECICE intramedullary limb lengthening system : a review of clinical effectiveness

by Young, Calvin, Adcock, Lorna
Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

152

Indwelling voice prostheses for adults following laryngectomy : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Wells, Charlotte, Adcock, Lorna
Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

153

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

154

Pharmacoeconomic review report: Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

155

Pharmacoeconomic review report: AbobotulinumtoxinA (Dysport therapeutic) : (Ipsen Biopharmaceuticals Canada, Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

156

CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic -- Ipsen Biopharmaceuticals Canada Inc.) : indication: for the symptomatic treatment of...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

157

Patient group input submissions: AbobotulinumtoxinA (Dysport therapeutic ULS) for the symptomatic treatment of focal spasticity affection the upper limbs in adults

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

158

Clinical review report: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

159

Pharmacoeconomic review report: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

160

CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease

Published 2017

Canadian Agency for Drugs and Technologies in Health

3
4
5
6
7
8
9
10
11
12
13